Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance
主要な著者: | Xu, S, Scott, C, Coleman, RL, Tuomilehto, J, Holman, RR |
---|---|
フォーマット: | Conference item |
言語: | English |
出版事項: |
Springer Nature
2019
|
類似資料
-
Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance
著者:: Xu, S, 等
出版事項: (2021) -
Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: insights from the Acarbose Cardiovascular Evaluation (ACE) trial
著者:: Wamil, M, 等
出版事項: (2020) -
Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): a longitudinal analysis of a randomized, double-blind, placebo-controlled trial
著者:: Leal, J, 等
出版事項: (2022) -
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
著者:: Holman, R, 等
出版事項: (2017) -
Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
著者:: Currie, G, 等
出版事項: (2017)